Rankings
▼
Calendar
COLL Q3 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q3 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$12M
+2828.9% YoY
Gross Profit
$11M
95.4% margin
Operating Income
-$13M
-112.4% margin
Net Income
-$13M
-111.0% margin
EPS (Diluted)
$-0.45
QoQ Revenue Growth
+235.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$123M
Total Liabilities
$26M
Stockholders' Equity
$96M
Cash & Equivalents
$108M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$408,000
+2828.9%
Gross Profit
$11M
$379,000
+2907.1%
Operating Income
-$13M
-$26M
+49.2%
Net Income
-$13M
-$26M
+49.8%
← FY 2017
All Quarters
Q4 2017 →